Targeting Myotonic Dystrophy Type 1 with Metformin

Myotonic dystrophy type 1 (DM1) is a multisystemic disorder of genetic origin. Progressive muscular weakness, atrophy and myotonia are its most prominent neuromuscular features, while additional clinical manifestations in multiple organs are also common. Overall, DM1 features resemble accelerated ag...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Puga, Mikel, Saenz-Antoñanzas, Ander, Matheu, Ander, López de Munain, Adolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910924/
https://www.ncbi.nlm.nih.gov/pubmed/35270043
http://dx.doi.org/10.3390/ijms23052901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910924/
https://www.ncbi.nlm.nih.gov/pubmed/35270043
http://dx.doi.org/10.3390/ijms23052901

Ejemplares similares